The Brazil clinical trials market was valued at USD 1.58 Billion in 2025, driven by rising biotechnology investments and strengthened regulatory support with enhanced infrastructure initiatives in the region. The market is anticipated to grow at a CAGR of 4.90% during the forecast period of 2026-2035, with the values likely to reach USD 2.55 Billion by 2035. The increasing prevalence of conditions such as diabetes, cancer, and cardiovascular diseases is driving demand for new treatments and, in turn, clinical research.
Base Year
Historical Period
Forecast Period
Brazil offers a genetically diverse and treatment-naïve patient pool, enabling faster recruitment and broader applicability of clinical trial results. There the market is expected to witness growth in the region.
Brazil's clinical trials market is witnessing an increased adoption of decentralized trial models and digital health tools, driven by regulatory reforms and a rising focus on patient-centric studies across diverse therapeutic areas.
The increasing government initiatives and regulatory reforms are enhancing the efficiency of clinical trials in Brazil, fostering growth by attracting global players and ensuring compliance with international standards.
Compound Annual Growth Rate
4.9%
Value in USD Billion
2026-2035
*this image is indicative*
According to Regulatory Focus factsheet, Brazil registered around 10,000 clinical studies by April 2024. Clinical trials are essential for advancing medical knowledge and ensuring the approval of new therapies. The market is growing rapidly due to favorable government policies, increasing investments, and a large, diverse patient population. Brazil's expanding healthcare infrastructure, combined with a rising demand for clinical research activities, makes the country an attractive destination for conducting clinical trials.
Rising Cancer Incidence to Accelerate the Market Growth
The increasing incidence of cancer is a major growth driver for the clinical trials market in Brazil. According to data published in July 2024, new cancer cases in Brazil rose significantly from approximately 489,000 in 2010 to about 704,000 in 2023. This sharp increase, especially in prostate cancer cases, is intensifying the need for innovative therapies, thereby supporting continued market growth in the forecast period.
Some of the notable trends in the market include the advent of new regulations to support clinical trials in the region:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase
Market Breakup by Service Type
Market Breakup by Therapeutic Areas
Market Breakup by Type of Pharmaceutical Product
Market Breakup by Study Design
Market Breakup by Delivery Model
Market Breakup by End User
Patient Recruitment Services Type Segmentation to Lead the Brazil Clinical Trials Market
The market is divided into a variety of service types, including laboratory services, bioanalytical testing services, patient recruitment, decentralized clinical trials, clinical trial supply and logistics, and more. Among these, patient recruitment services are expected to dominate. The effectiveness of a clinical trial often depends on the speed and accuracy of patient recruitment, which is essential for timely trial completion and accurate results. As the demand for clinical trials across therapeutic areas continues to grow, efficient patient recruitment will be a significant driver of market success in Brazil.
Oncology to Witness Substantial Growth in the Market Segmentation by Therapeutic Areas
There is an emphasis clinical trials on several therapeutic areas, including oncology, infectious diseases, neurology, cardiology, and metabolic disorders, among others. According to projections by the Brazilian National Cancer Institute (INCA), Brazil is expected to record over 704,000 new cancer cases each year between 2023 and 2025, excluding non-melanoma skin cancers. As a result, oncology is projected to be the leading therapeutic area due to the increasing prevalence of cancer in Brazil and worldwide. With rising investments in cancer research and the growing demand for new treatment options, clinical trials in oncology are expected to dominate. These trials are pivotal for the development of cutting-edge cancer therapies, making oncology a focal point of clinical research in the Brazilian market.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Cohortias, established as a full-service Contract Research Organization (CRO) that specializes in clinical trials across Latin America. Established to meet the growing demand for clinical research, Cohortias offers services like early-phase studies, rescue studies, and phase II and III trials, along with medical device trials. They are renowned for their expansive network, with over 250 sites and 10,500 conducted studies. Cohortias focuses on therapeutic areas including oncology, cardiology, and infectious diseases, playing a pivotal role in advancing clinical research in Brazil and the wider Latin American region.
Parexel operates across multiple regions, including Brazil, where it supports clinical trial services. The company offers end-to-end clinical development services. Parexel specializes in phases I-IV trials, helping accelerate drug development globally. Their involvement in Brazil’s clinical trials market is vital due to its vast patient population and the company’s deep expertise in clinical, regulatory, and market access solutions, supporting a wide range of trials, including rare diseases and vaccines.
PPD, a Thermo Fisher Scientific company, focuses on early-phase clinical trials, particularly Phase I and Ib studies, assessing the clinical relevance and commercial viability of compounds. Their services include patient recruitment, investigator engagement, and trial design, ensuring the success of subsequent trials. PPD’s expertise in early clinical development leverages extensive global resources, making them a significant player in the clinical trials market, supporting both patient safety and regulatory submission processes.
ICON plc is a prominent global Contract Research Organization (CRO). It was established in 1990 and is headquartered in Dublin, Ireland. With a significant presence in Latin America, including Brazil, ICON conducts clinical trials across various therapeutic areas, including cardiovascular, cancer, and infectious diseases. ICON’s expertise in local regulations, patient enrollment, and cultural understanding allows it to effectively manage complex clinical trials. The company’s commitment to high-quality research and patient retention has solidified its leadership in Brazil's growing clinical trials market, making it a trusted partner for global and regional study delivery.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Fractals Clinical Research, IQVIA Inc., Medpace, ACTIVA-CRO, and Centre International de Développement Pharmaceutique Ltee (CIDP).
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Phase |
|
| Breakup by Service Type |
|
| Breakup by Therapeutic Areas |
|
| Breakup by Pharmaceutical Product |
|
| Breakup by Study Design |
|
| Breakup by Delivery Model |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share